A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

OBJECTIVE: To determine whether glargine is noninferior to detemir regarding the percentage of patients reaching A1C <7% without symptomatic hypoglycemia ≤3.1 mmol/l. RESEARCH DESIGN AND METHODS: In this 24-week trial, 973 insulin-naive type 2 diabetic patients on stable oral glucose-lowering dru...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Swinnen, Sanne G., Dain, Marie-Paule, Aronson, Ronnie, Davies, Melanie, Gerstein, Hertzel C., Pfeiffer, Andreas F., Snoek, Frank J., DeVries, J. Hans, Hoekstra, Joost B., Holleman, Frits
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Diabetes Association 2010
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875419/
https://ncbi.nlm.nih.gov/pubmed/20200301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-2294
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge